![]() |
市場調査レポート
商品コード
1775649
動脈切開閉鎖装置市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2025年~2032年Arteriotomy Closure Devices Market Size, Share, and Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
動脈切開閉鎖装置市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2025年~2032年 |
出版日: 2025年07月18日
発行: SkyQuest
ページ情報: 英文 198 Pages
納期: 3~5営業日
|
動脈切開閉鎖装置の世界市場規模は2023年に18億米ドルと評価され、2024年の19億4,000万米ドルから2032年には34億5,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは7.5%で成長する見通しです。
動脈切開閉鎖装置の世界市場は、世界の主要死亡原因である心血管疾患の有病率の上昇が拍車をかけ、力強い成長を遂げています。血管形成術や冠動脈カテーテル治療などのインターベンショナル手技の増加により、特にそのような治療が行われる病院内では、信頼性の高い閉鎖ソリューションの必要性が高まっています。従来の病院への依存が続く一方で、コスト削減と回復時間の短縮を提供する外来血管処置の魅力により、外来手術センターでの採用が顕著に増加しています。しかし、高度な閉鎖技術へのアクセスが限られている中低所得国では課題が残っています。市場参入企業は、地理的拡大、手頃な価格の実現、的を絞ったトレーニングイニシアティブを通じてこうした課題に対処しており、それによって市場の成長軌道を強化しています。
Global Arteriotomy Closure Devices Market size was valued at USD 1.8 billion in 2023 and is poised to grow from USD 1.94 billion in 2024 to USD 3.45 billion by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).
The global market for arteriotomy closure devices is witnessing robust growth, spurred by the escalating prevalence of cardiovascular diseases, which are a primary cause of mortality worldwide. The increasing number of interventional procedures such as angioplasty and coronary catheterization has amplified the need for reliable closure solutions, particularly within hospitals where most such treatments occur. While traditional reliance on hospitals persists, there is a notable uptick in adoption within ambulatory surgical centers due to the appeal of outpatient vascular procedures that offer cost savings and quicker recovery times. However, challenges remain in low- and middle-income countries, where access to advanced closure technologies is limited. Market players are addressing these challenges through geographic expansion, enhanced affordability, and targeted training initiatives, thereby reinforcing the market's growth trajectory.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Arteriotomy Closure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Arteriotomy Closure Devices Market Segments Analysis
Global Arteriotomy Closure Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Active Closure Devices and Passive Closure Devices. Based on Application, the market is segmented into Femoral Arterial Access Procedures and Radial Arterial Access Procedures. Based on End User, the market is segmented into Hospitals, Ambulatory Care Centers and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Arteriotomy Closure Devices Market
The increasing prevalence of interventional procedures such as coronary angiography, percutaneous coronary intervention (PCI), transcatheter aortic valve replacement (TAVR), and peripheral artery interventions is driving the demand for arteriotomy closure devices. As the number of these procedures rises, the need for efficient hemostasis, shorter recovery times, and a decrease in complications, such as hematomas and excessive bleeding, becomes more critical. Consequently, vascular closure devices have become essential components in providing care following femoral and radial access catheterizations. This growing trend underscores the importance of innovative solutions in the global arteriotomy closure devices market.
Restraints in the Global Arteriotomy Closure Devices Market
A significant barrier to the widespread adoption of arteriotomy closure devices, particularly in developing economies, is their high cost. While manual compression methods are more affordable, healthcare institutions in budget-restricted regions face challenges due to limited reimbursement options, price-sensitive procurement strategies, and inadequate infrastructure to support advanced technologies. As a result, many hospitals in emerging markets, such as those in Southeast Asia and Latin America, continue to rely on manual closure techniques because the newer devices are financially unfeasible. This situation underscores the need for more accessible solutions that can facilitate greater integration of advanced closure systems in these settings.
Market Trends of the Global Arteriotomy Closure Devices Market
The Global Arteriotomy Closure Devices market is experiencing a significant trend towards the adoption of minimally invasive and large-bore interventions, driven by an increased preference for efficient vascular closure solutions that enhance patient outcomes. With the rapid proliferation of procedures like TAVR and EVAR in both developed and emerging markets, the demand for advanced closure devices is on the rise. Innovations such as Abbott's latest iteration of the Perclose ProStyle system, launched in early 2025, cater specifically to high-volume catheterization labs, offering faster deployment and improved control to mitigate operator variability and reduce post-operative complications. This trend underscores a shift towards more effective and patient-friendly surgical solutions in the cardiovascular landscape.